Clinical Trial Update: American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating American ginseng extract for preventing respiratory infection and reducing antibiotic use in patients with leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• American ginseng extract

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-11-02